Zolfaghari Sima, Kaasbøll Ole Jørgen, Ahmed M Shakil, Line Fabian A, Hagelin Else Marie V, Monsen Vivi T, Attramadal Håvard
Institute for Surgical Research, Oslo University Hospital, Rm. A3.1056, Sognsvannsveien 20, Nydalen, P.O. Box 4950, 0424, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
J Cell Commun Signal. 2022 Sep;16(3):377-395. doi: 10.1007/s12079-021-00659-7. Epub 2021 Dec 1.
CCN5 is a divergent member of the cellular communication network factor (CCN) family in that it lacks the carboxyl terminal cystine knot domain common to the other CCN family members. CCN5 has been reported to antagonize the profibrotic actions of CCN2 and to inhibit myocardial collagen deposition and fibrosis in chronic pressure overload of the heart. However, what mechanisms that regulate CCN5 activity in the heart remain unknown. Recombinant, replication defective adenovirus encoding firefly luciferase under control of the human CCN5 promoter was prepared and used to investigate what mechanisms regulate CCN5 transcription in relevant cells. Tissue distribution of CCN5 in hearts from healthy mice and from mice subjected to myocardial infarction was investigated. Contrary to the profibrotic immediate early gene CCN2, we find that CCN5 is induced in the late proliferation and maturation phases of scar healing. CCN5 was identified principally in endothelial cells, fibroblasts, smooth muscle cells, and macrophages. Our data show that CCN5 gene transcription and protein levels are induced by catecholamines via β-adrenergic receptors. Myocardial induction of CCN5 was further confirmed in isoproterenol-infused mice. We also find that CCN5 transcription is repressed by TNF-α, an inflammatory mediator highly elevated in early phases of wound healing following myocardial infarction. In conclusion, CCN5 predominates in endothelial cells, fibroblasts, and macrophages of the differentiating scar tissue and its transcription is conversely regulated by β-adrenergic agonists and TNF-α.
CCN5是细胞通讯网络因子(CCN)家族中一个不同寻常的成员,因为它缺乏其他CCN家族成员共有的羧基末端胱氨酸结结构域。据报道,CCN5可拮抗CCN2的促纤维化作用,并抑制心脏慢性压力超负荷时的心肌胶原沉积和纤维化。然而,调节心脏中CCN5活性的机制仍不清楚。制备了在人CCN5启动子控制下编码萤火虫荧光素酶的重组、复制缺陷型腺病毒,并用于研究在相关细胞中调节CCN5转录的机制。研究了CCN5在健康小鼠和心肌梗死小鼠心脏中的组织分布。与促纤维化的早期即刻基因CCN2相反,我们发现CCN5在瘢痕愈合的晚期增殖和成熟阶段被诱导。CCN5主要在内皮细胞、成纤维细胞、平滑肌细胞和巨噬细胞中被鉴定。我们的数据表明,儿茶酚胺通过β-肾上腺素能受体诱导CCN5基因转录和蛋白质水平。在异丙肾上腺素注射的小鼠中进一步证实了心肌对CCN5的诱导作用。我们还发现,TNF-α可抑制CCN5转录,TNF-α是心肌梗死后伤口愈合早期高度升高的一种炎症介质。总之,CCN5在分化的瘢痕组织的内皮细胞、成纤维细胞和巨噬细胞中占主导地位,其转录受β-肾上腺素能激动剂和TNF-α的反向调节。